2023. The efficacy of administering elbasvir/grazoprevir as hepatitis C therapy in hemodialysis patients with comorbid of hypertension and diabetes mellitus. Jurnal Penyakit Dalam Udayana. 7, 2 (Dec. 2023), 35–38. DOI:https://doi.org/10.36216/jpd.v7i2.228.